Del100 and del231 were originally identified while studying the impact of NMD on hereditary tyrosinemia type I. During the characterization of the effects of the W262X mutation on FAH mRNA metabolism [29], we detected two minor alternative transcripts. This evidence concerns the gene FAH and Tyrosinemia type 1.